What is Micrima?
Founded in 2006 and headquartered in Bristol, UK, Micrima Ltd. is at the forefront of developing advanced radio-wave technology specifically designed for the early detection of breast cancer. This pioneering approach aims to provide a non-invasive and potentially more accurate diagnostic tool, addressing a critical need in women's health. The company's commitment to innovation in medical technology positions it as a key player in the health tech sector.
How much funding has Micrima raised?
Micrima has raised a total of $14.2M across 3 funding rounds:
Unspecified
$3.4M
Private Equity
$5.6M
Unspecified
$5.2M
Unspecified (2016): $3.4M with participation from Technology Venture Partners, Swarraton Partners, Angel CoFund, and University of Bristol Enterprise Fund
Private Equity (2018): $5.6M led by Venture Founders, Technology Venture Partners, and Angel CoFund
Unspecified (2021): $5.2M supported by Technology Venture Partners LLC
Key Investors in Micrima
Technology Venture Partners LLC
Technology Venture Partners LLC is an entity involved in venture capital and private equity, likely focusing on technology-driven companies.
Technology Venture Partners
Technology Venture Partners is a venture capital firm based in Tulsa, Oklahoma, specializing in technology investments.
Angel CoFund
Angel CoFund is a UK-based investment fund that supports promising businesses through angel and co-investment, collaborating with experienced angel investors.
What's next for Micrima?
With substantial enterprise-level funding and a recent strategic investment, Micrima is poised for significant growth and expansion. The capital infusion is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach, potentially leading to wider adoption of its breast cancer detection technology. This strategic financing indicates a mature stage for the company, likely focusing on scaling operations and solidifying its market position in the competitive medical diagnostics landscape.
See full Micrima company page
